KR930701975A - 항체 탐지를 위한 검사 시스템의 민감성 그리고/혹은 특이성을 결정하는 방법 - Google Patents

항체 탐지를 위한 검사 시스템의 민감성 그리고/혹은 특이성을 결정하는 방법

Info

Publication number
KR930701975A
KR930701975A KR1019930701388A KR930701388A KR930701975A KR 930701975 A KR930701975 A KR 930701975A KR 1019930701388 A KR1019930701388 A KR 1019930701388A KR 930701388 A KR930701388 A KR 930701388A KR 930701975 A KR930701975 A KR 930701975A
Authority
KR
South Korea
Prior art keywords
antibody
antigen
complex
lgm
lga
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019930701388A
Other languages
English (en)
Korean (ko)
Inventor
비. 오스더 커어트
에이취. 켈러만 가트프레드
Original Assignee
제랄드 에프. 버크
베리겐 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제랄드 에프. 버크, 베리겐 인코포레이티드 filed Critical 제랄드 에프. 버크
Publication of KR930701975A publication Critical patent/KR930701975A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1019930701388A 1990-11-09 1991-11-06 항체 탐지를 위한 검사 시스템의 민감성 그리고/혹은 특이성을 결정하는 방법 Ceased KR930701975A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61130790A 1990-11-09 1990-11-09
US07/611,307 1990-11-09
PCT/US1991/008296 WO1992008471A1 (en) 1990-11-09 1991-11-06 Method for determining the sensitivity and/or specificity of an assay system for detecting antibodies

Publications (1)

Publication Number Publication Date
KR930701975A true KR930701975A (ko) 1993-09-08

Family

ID=24448512

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930701388A Ceased KR930701975A (ko) 1990-11-09 1991-11-06 항체 탐지를 위한 검사 시스템의 민감성 그리고/혹은 특이성을 결정하는 방법

Country Status (7)

Country Link
EP (1) EP0556327A1 (enrdf_load_stackoverflow)
JP (1) JPH06502723A (enrdf_load_stackoverflow)
KR (1) KR930701975A (enrdf_load_stackoverflow)
AU (1) AU650707B2 (enrdf_load_stackoverflow)
CA (1) CA2055177A1 (enrdf_load_stackoverflow)
FI (1) FI932080L (enrdf_load_stackoverflow)
WO (1) WO1992008471A1 (enrdf_load_stackoverflow)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2134080C (en) * 1992-04-24 2004-07-13 Toby C. Rodman Natural humain igm antibodies
US5587293A (en) * 1994-01-06 1996-12-24 Terrapin Technologies, Inc. Method to identify binding partners
CA2178096C (en) * 1994-01-06 2004-03-09 Lawrence M. Kauvar Surrogates for targets and improved reference panels
US8034904B2 (en) 2002-06-14 2011-10-11 Immunogen Inc. Anti-IGF-I receptor antibody
US9321664B2 (en) 2011-12-20 2016-04-26 Ecolab Usa Inc. Stable percarboxylic acid compositions and uses thereof
CN106396037B (zh) 2012-03-30 2019-10-15 艺康美国股份有限公司 过乙酸/过氧化氢和过氧化物还原剂用于处理钻井液、压裂液、回流水和排放水的用途
US12096768B2 (en) 2019-08-07 2024-09-24 Ecolab Usa Inc. Polymeric and solid-supported chelators for stabilization of peracid-containing compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4022878A (en) * 1972-05-15 1977-05-10 Biological Developments, Inc. Methods and compounds for producing specific antibodies
US4007008A (en) * 1975-07-30 1977-02-08 Becker Milton J Preparation of reference serum from animal blood
US4816253A (en) * 1977-12-08 1989-03-28 Likhite Vilas V Novel mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent
JPS59227827A (ja) * 1983-06-10 1984-12-21 Nippon Koutai Kenkyusho:Kk マラリア原虫由来糖鎖関連抗原及びその製造法
US4727037A (en) * 1984-02-15 1988-02-23 Cetus Corporation Assay kit and method for the determination of antibody class and subclass
US4774177A (en) * 1985-07-15 1988-09-27 Vet-Test Partners Immunoassay method for detection of antibodies and antigens
US5059520A (en) * 1986-08-27 1991-10-22 Sloan-Kettering Institute For Cancer Research Monoclonal antibody panel for blood group a antigen
US5006464A (en) * 1987-10-01 1991-04-09 E-Y Laboratories, Inc. Directed flow diagnostic device and method
IE81146B1 (en) * 1987-10-13 2000-05-03 Terrapin Tech Inc Method to produce immunodiagnostic reagents
US5008183A (en) * 1988-05-10 1991-04-16 Bio-Research Laboratories, Inc. Assay system for detecting antibody and a method of producing non-human immune antibody

Also Published As

Publication number Publication date
EP0556327A4 (enrdf_load_stackoverflow) 1994-08-31
AU9094291A (en) 1992-06-11
JPH06502723A (ja) 1994-03-24
FI932080A0 (fi) 1993-05-07
FI932080A7 (fi) 1993-05-07
CA2055177A1 (en) 1992-05-10
EP0556327A1 (en) 1993-08-25
WO1992008471A1 (en) 1992-05-29
AU650707B2 (en) 1994-06-30
FI932080L (fi) 1993-05-07

Similar Documents

Publication Publication Date Title
Aubert et al. Recombinant antigens to detect Toxoplasma gondii-specific immunoglobulin G and immunoglobulin M in human sera by enzyme immunoassay
Mahieux et al. Human T-cell lymphotropic virus type 1 gag indeterminate western blot patterns in Central Africa: relationship to Plasmodium falciparum infection
DE68916421T2 (de) Synthetische peptidantigene zum nachweis von htlv-1-infektionen.
Karim et al. The relationship and significance of antibody titres as determined by various serological methods in glandular and ocular toxoplasmosis.
ATE109830T1 (de) Expression von virusproteinen mit immunologischer aktivität.
EP0476130A4 (en) Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof
KR930701975A (ko) 항체 탐지를 위한 검사 시스템의 민감성 그리고/혹은 특이성을 결정하는 방법
CA1305411C (en) Method for the determination of anti-hiv, means therefore and theiruse in this method
Archambault et al. Development of an enzyme-linked immunosorbent assay for equine infectious anemia virus detection using recombinant Pr55gag
Hosie et al. Suppression of virus burden by immunization with feline immunodeficiency virus Env protein
SE9000595L (sv) Nya peptider, diagnostiska antigener och ett immunanalysfoerfarande
US5264342A (en) Method for determining the sensitivity and/or specificity of an assay system for detecting antibodies
Bürki et al. Equine lentivirus, comparative studies on four serological tests for the diagnosis of equine infectious anaemia
Mockett et al. The use of an enzyme-linked immunosorbent assay to detect IgG antibodies to serotype-specific and group-specific antigens of fowl adenovirus serotypes 2, 3 and 4
GR3033885T3 (en) Synthetic antigens for the detection of aids-related disease caused by LAV-2.
Issel et al. Evolution of equine infectious anemia diagnostic tests: recognition of a need for detection of anti-EIAV glycoprotein antibodies
Janvier et al. Immune response to a major epitope of p24 during infection with human immunodeficiency virus type 1 and implications for diagnosis and prognosis
Lal et al. A synthetic peptide elicits antibodies reactive with the external glycoprotein of human T cell lymphotropic virus type I
ES2094124T3 (es) Ensayo-inmunologico de anticuerpos contra hiv.
SE9101863D0 (sv) Peptider, diagnostiskt antigen, vaccinkomposition och foerfarande foer selektering av hiv-stammar
Thomas et al. Rubella-specific IgG subclass concentrations in sera using an enzyme-linked immunosorbent assay (ELISA): the effect of different sources of rubella antigen
Sirivichayakul et al. Evaluation of a 2-minute anti-human immunodeficiency virus (HIV) test using the autologous erythrocyte agglutination technique with populations differing in HIV prevalence
US7026133B2 (en) Method and composition for the diagnosis of equine infectious anemia virus disease by using the recombinant capsid protein virus (p26)
Walrand et al. Incidence of bovine leukemia virus‐specific antibodies in west african cattle
SU712091A1 (ru) Способ определени антигена или антител е вируса гепатита в

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930508

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19961015

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19930508

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 19981126

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 19990804

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 19981126

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I